Evaluation of the Use of Antibiotics in Covid-19 Patients at X Muara Bulian Hospital in 2022
DOI:
https://doi.org/10.56778/rjhs.v1i3.194Abstract
Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus2 (SARSCoV2). Treatment for COVID-19 is still uncertain, so various treatment efforts have been carried out, including administering antibiotics. This research is a type of non-experimental research and uses a descriptive research design. Data collection was carried out retrospectively. Data collection from medical records of COVID-19 patients in 2022 at Hospital X Muara Bulian. The population of 86 patients, a sample of 46 patients. The research results showed that 69.57% of patients were male, 32.61% of patients were aged 36–45 years, and Covid-19 patients received the most antibiotic therapy, namely azithromycin in the macrolide group at a dose of 500 mg for 5 days with a percentage of 69.57%, The accuracy of the indication, dose, and duration of administration of antibiotics is 100% following the COVID-19 Management Guidelines, Edition 2 of 2020, and no drug interactions have occurred. This research is based on existing literature. It is hoped that future researchers will use a larger sample size than this study so that they can understand demographic characteristics, patterns of antibiotic use, rational use of drugs, and drug interactions that occur.
References
Agustin, O.A. & Fitrianingsih, F., (2020). Kajian Interaksi Obat Berdasarkan Kategori Signifikansi Klinis Terhadap Pola Peresepan Pasien Rawat Jalan Di Apotek X Jambi. Electronic Journal Scientific of Environmental Health And Disease.
Ariyani, H., Fitriani, S., & Rahmah, S. (2021). Profil Penggunaan Obat pada Pasien COVID-19 di Rumah Sakit Umum Daerah Ulin Banjarmasin. Jurnal Pharmascience.Vol 8, No.2.133-148.
BPOM. (2021). Penetapan Informatorium Obat Corona Virus Disease 2019 (COVID-19) Di Indonesia Edisi 3.
Burhan, E., et al. (2020). Pedoman Tatalaksana Covid-19. (Edisi 3). Tim Editor Perhimpunan Dokter Paru Indonesia (PDPI) Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI) Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI) Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN) Ikatan Dokter Anak Indonesia (IDAI).
Davies, P. D. O. (2002). Multi-drug resistant tuberculosis. CPD Infection.
Ernawati, A. (2021). Tinjauan Kasus COVID-19 Berdasarkan Jenis Kelamin, Golongan Usia, dan Kepadatan Penduduk di Kabupaten Pati. Jurnal Litbang: Media Informasi Penelitian. Pengembangan dan IPTEK.Vol. 17. No.2. 131-146.
Health Organization, W. (2022). Guideline Therapeutics and COVID-19: living guideline.
Hidayah, S. N., Izah, N., & Andari, I. D. (2020). Peningkatan Imunitas dengan Konsumsi Vitamin C dan Gizi Seimbang Bagi Ibu Hamil Untuk Cegah Corona Di Kota Tegal. Jurnal Abdinus : Jurnal Pengabdian Nusantara. 4.1. 170-174.
Kartikawati, D. R. (2021). Tanggung Jawab Rumah Sakit terhadap Pemenuhan Hak Pasien pada Masa Pandemi COVID-19. Indonesia Law Reform Journal. Vol 1. No.3. 318-335.
Kemenkes RI. (2019). Peraturan Menteri Kesehatan Nomor 30 Tahun 2019 tentang Klasifikasi dan Perizinan Rumah Sakit.
Kementrian kesehatan republik indonesia. (2011). Modul Penggunaan Obat Rasional 2011. Bina Pelayanan Kefarmasian, jakarta.
Lisni, I., Mujianti, D., & Anggriani, A. (2021). Profil Antibiotik Untuk Pengobatan Pasien Covid-19 di Suatu Rumah Sakit di Bandung. Jurnal Ilmiah Farmako Bahari, 12. No.2. 99-106
Maharianingsih, N. M., Sudirta, I. K., & Suryaningsih, N. P. A., (2022). Karakteristik Pasien dan Penggunaan Obat pada Pasien Covid-19 Derajat Sedang Hingga Berat. Indonesian Journal of Pharmaceutical Education.2(2). 101-100.
Mardianto, R., Yulia, R., & Herawati, F. (2022). Profil Penggunaan Antibiotiik pada Pasien Covid-19 di Rumah Sakit dr. Soepraoen Malang. Tunas Riset Kesehatan. 12. No.2. 113-121.
Mudzakkir, M., Risnasari, N., Nugraha, M. F. E., & Mawadha, S. A. (2021). Upaya Pencegahan Penularan Covid-19 pada Masyarakat Kab. Kediri. Kontribusi: Jurnal Penelitian Dan Pengabdian Kepada Masyarakat. 2. No.1. 56-65.
Pepitasari, B. D., & Anggraini, T. D. (2021). Gambaran Tatalaksana Terapi pada Pasien Coivd-19 Terkonfirmasi di Rumah Sakit X Kota Surakarta Periode Maret - Desember 2020. Indonesian Journal on Medical Science. 8. No.2.
Prasetya Ningrum, E., Pratiwi, A. D. E., & Adhityasamara, D. (2021). Penggunaan Antibiotika Pada Pasien Covid-19 di Rumah Sakit "X" Kota Semarang. Cendekia eksakata. 6(2).
Ramadhan, M. F., & Lestari, F. (2022). Profil Peresepan Terapi Obat Covid-19 pada Pasien Rawat Inap di Rumah Sakit Santosa Hospital Bandung Kopo Periode Juni - Juli 2021. In Bandung Conference Series: Pharmacy. Vol 2. No.2. 1109-1115.
Riswanto, S. R., Basuki, D. R., & Romdhoni, M. F. (2018). Hubungan Penggunaan Antibiotik Dengan Tingkat Kekambuhan Ispa Pada Balita Di Puskesmas Cilembang Kota Tasikmalaya Periode 1 Januari – 31 Desember 2016. Saintika Medika. 13(1).
Sanjaya, T. (2020). Penerapan Komputer Dalam Mengidentifikasi Virus dan Bakteri Penyakit Ichtyosis Menerapkan Algoritma Rete. Journal of Pharmaceutical and Health Research, 1(2), 43–48.
Susilo, A., et al (2020). Tinjauan Pustaka. In Jurnal Penyakit Dalam Indonesia | (Vol. 7, Issue 1).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 RADINKA JOURNAL OF HEALTH SCIENCE
This work is licensed under a Creative Commons Attribution 4.0 International License.
<meta name="google-site-verification" content="qBtkk8rnBm0ZRgy_14UYrahahLnkC844dKsDOFjzrn4" />
